<div><p>Groups of mice (C57BL/6 strain and BALB/c strain) were immunized twice 15 days apart with vehicle medium (mock), YF vaccine (17 DD), recombinant 17 D SIV-Gag <sub>45-269</sub> or recombinant 17 D Δ IRES virus. Spleen cells of each mouse were recovered 14 days after second immunization and cultured with 2 μg/mL of YF CD8 specific peptides (Panel A-C) or 5 mM of SIV Gag peptide pool (Panel D-F). Results are representative of three independent experiments and are normalized to non-stimulated cells control. Bars represent the medians. Statistics were done by Mann-Whitney T test. </p> <p>* <i>p</i><0.05, ** <i>p</i><0.01, *** <i>p</i><0.001.</p></div
<p>Groups of mice were vaccinated with10<sup>7</sup> cfu BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-...
<p>Groups of mice were primed with the indicated rBCG vaccines (10<sup>7</sup> cfu or 10<sup>5</sup>...
<p>Mice were vaccinated with BCG[pHS207], [pWB105], [pWB106] and [pWB206] (intranasal, 10<sup>7</sup...
<p>Neutralizing antibodies levels, Total YF- IgG levels and IgG2a/ IgG1 ratios in mice sera followin...
<p>ICCS for YF-specific and Gag-specific CD8<sup>+</sup> T-cells at day 14 after immunization on se...
<p>ICCS for YF-specific and Gag-specific CD4<sup>+</sup> T-cells at day 14 after immunization on sec...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>We used the same approach described in the legend of <a href="http://www.plosone.org/article/info...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>At one week after the rAd5 vaccination, we obtained PBMC from all animals and performed ICS to de...
After 3 immunizations, fresh splenocytes were pooled and purified, then CD8+ T cells were tested by ...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>Percentages of CD8<sup>+</sup> IFN- γ<sup>+</sup> cells in draining lymph nodes and spleens of mi...
<p>We determined the breadth of T-cell responses in each animal by adding the number of positive IFN...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>Groups of mice were vaccinated with10<sup>7</sup> cfu BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-...
<p>Groups of mice were primed with the indicated rBCG vaccines (10<sup>7</sup> cfu or 10<sup>5</sup>...
<p>Mice were vaccinated with BCG[pHS207], [pWB105], [pWB106] and [pWB206] (intranasal, 10<sup>7</sup...
<p>Neutralizing antibodies levels, Total YF- IgG levels and IgG2a/ IgG1 ratios in mice sera followin...
<p>ICCS for YF-specific and Gag-specific CD8<sup>+</sup> T-cells at day 14 after immunization on se...
<p>ICCS for YF-specific and Gag-specific CD4<sup>+</sup> T-cells at day 14 after immunization on sec...
<p>WT B6 mice, H-2K<sup>b</sup> KO mice, β2m KO mice, IFN-γ/Prf double KO mice and MHC class II KO m...
<p>We used the same approach described in the legend of <a href="http://www.plosone.org/article/info...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>At one week after the rAd5 vaccination, we obtained PBMC from all animals and performed ICS to de...
After 3 immunizations, fresh splenocytes were pooled and purified, then CD8+ T cells were tested by ...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>Percentages of CD8<sup>+</sup> IFN- γ<sup>+</sup> cells in draining lymph nodes and spleens of mi...
<p>We determined the breadth of T-cell responses in each animal by adding the number of positive IFN...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
<p>Groups of mice were vaccinated with10<sup>7</sup> cfu BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-...
<p>Groups of mice were primed with the indicated rBCG vaccines (10<sup>7</sup> cfu or 10<sup>5</sup>...
<p>Mice were vaccinated with BCG[pHS207], [pWB105], [pWB106] and [pWB206] (intranasal, 10<sup>7</sup...